Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06755346Phase 1Withdrawn
Phase 1, randomised, double-blind trial of cannabis (5 arms). Primary endpoints: Number of participants with treatment-related sperm parameters at 30 minutes, Number of participants with treatment-related sperm epimutation at 30 minutes and 1 more. Planned start Apr 2025; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06755346.